
Mainboard
Invicta Diagnostic Ltd., incorporated in 2023, is a SEBI-registered financial intermediary offering regulated services across equity, derivatives, commodities, and depository segments. The Company is a registered member of NSE, BSE, MCX, and a Depository Participant with CDSL, enabling compliant, secure, and efficient participation in India’s capital markets.
Its core services include equity and F&O broking, investment advisory, research analytics, and wealth management, supported by standardized processes, robust risk frameworks, and technology-enabled execution systems. Invicta Diagnostic Ltd. is guided by experienced leadership with domain expertise and follows strict adherence to SEBI and exchange regulations to ensure transparency, governance, and investor protection.
With a strong emphasis on data security, ethical conduct, and client-centric service delivery, the Company focuses on providing reliable market access and informed decision support. Invicta Diagnostic Ltd. positions itself as a trusted and responsible participant in the capital-markets ecosystem through disciplined operations and long-term value orientation.